“The findings from this new poll are a stark reminder of the work we must do to save the 340B program – most importantly, to support the vulnerable and low-income communities that rely on it to help them access their medications. Through greater transparency, accountability, and oversight of the program, we can get 340B back on track so it fully benefits patients,” said former Illinois Congressman and AIR340B Spokesman Bob Dold.